Posted by Michael Wonder on 01 Apr 2022
Price slashed for revolutionary $78,000 a year prostate cancer treatment Lynparza
1 April 2022 - A new subsidy for a revolutionary drug is set to benefit thousands of Aussie men with aggressive prostate cancer. See how it works.
The $78,000 a year treatment Lynparza is already subsidised for use by women whose breast cancer is linked to BRCA1 and BRCA2 genes.
